SASH3 and squamous cell lung carcinoma: Meanwhile, low expression of SASH3 in cancer was observed in bladder urothelial carcinoma (BLCA), colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), LUAD, lung squamous cell carcinoma (LUSC), and rectum adenocarcinoma (READ) (Figure 1A).